Enhancing clinical data management with SAS

SAS has introduced the Clinical Acceleration Repository, a cloud-native platform designed to streamline the complex management of clinical trial data. By centralizing data sources and ensuring strict regulatory compliance through robust audit trails, this solution addresses the common industry bottleneck of disorganized data governance. This consolidation allows life sciences organizations to prepare data for statistical analysis more efficiently, significantly reducing the time required for regulatory submissions and accelerating the path to bringing new therapies to market. Complementing this infrastructure is SAS Data Maker, which generates statistically accurate synthetic data to support AI development and model training. This tool mitigates critical challenges related to patient privacy and data scarcity, enabling researchers to simulate rare scenarios without compromising sensitive health information. For companies like AstraZeneca, this capability means data scientists can innovate faster and make more informed decisions by accessing high-quality, compliant datasets that augment limited real-world information. These innovations are highly relevant to open data principles as they demonstrate how sophisticated data management and AI-driven generation can enhance the accessibility and utility of health information while maintaining rigorous security standards. By providing open environments that support third-party tools and integrating diverse data sources, SAS helps break down data silos. This approach illustrates the broader potential for open data ecosystems to foster transparency, collaboration, and faster discovery in the healthcare sector without sacrificing the privacy and integrity essential to clinical research.

Source: gadget.co.za
Published on 2024-07-22

Enhancing clinical data management with SAS

Related news